Phathom Pharmaceuticals Inc — Cash Flow (NASDAQ:PHAT) | MetaTrader

Open full chart

Financials

Overview Rapor Statistics Dividends

Quarterly Annual

Cash from operating activities -69.69 M148.62 M146.53 M137.58 M266.77 M166.78 M 166.78 M Cash from investing activities 1.04 M328 K1.04 M1.63 M135 K229 K 229 K Cash from financing activities 114.46 M44.71 M120.04 M367.58 M182.77 M288 K 288 K Free cash flow -70.73 M148.29 M145.49 M135.95 M266.63 M166.55 M 166.55 M

Haberler

Guggenheim, Phathom hissesi için hedef fiyatı 25 dolara yükseltti

Phathom Pharmaceuticals, Inc. (PHAT) Q4 2025 Earnings Call Transcript

Stifel, Phathom hissesi için Al tavsiyesini yineledi

Stifel reiterates Buy on Phathom stock, keeps $28 price target

Phathom’un 4Ç 2025 sonuçları: %217 gelir artışı, kârlılık yakın

Phathom Q4 2025 slides: 217% revenue growth, profitability in sight

Phathom Pharma kazancı $0,34 ile beklentilere göre daha iyi, kâr ise beklentilere göre yüksek

Phathom Pharma earnings beat by $0.34, revenue topped estimates

Iovance Biotherapeutics (IOVA) Reports Q4 Loss, Tops Revenue Estimates

Phathom Pharmaceuticals stock maintains Buy rating at Stifel on strong revenue outlook

Cantor Fitzgerald, Phathom hissesi için Ağırlık Üstü notunu 29 dolar hedefle yineledi

Cantor Fitzgerald reiterates Overweight rating on Phathom stock at $29